Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen S Chung

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Leukemia Research|April 27, 2024
Racial and ethnic disparities in Acute Myeloid Leukemia: 15-year experience at a safety net hospital systemSharlene Dong, Naveen Premnath, Navid Sadeghi, et al.
Nature Communications|May 5, 2023
Neutrophil metabolomics in severe COVID-19 reveal GAPDH as a suppressor of neutrophil extracellular trap formationYafeng Li, Jessica S Hook, Qing Ding, et al.
Seminars in Oncology|December 5, 2012
A 75-year-old woman with thoracic spinal cord compression and chloroma (granulocytic sarcoma)Madhava Baikaidi, Stephen S Chung, Martin S Tallman, et al.
Nature Communications|November 4, 2021
Convergence of oncogenic cooperation at single-cell and single-gene levels drives leukemic transformationYuxuan Liu, Zhimin Gu, Hui Cao, et al.
Circulation Research|September 5, 2009
Aldose reductase protects against early atherosclerotic lesion formation in apolipoprotein E-null miceSanjay Srivastava, Elena Vladykovskaya, Oleg A Barski, et al.
Blood|January 31, 2015
miR-29a maintains mouse hematopoietic stem cell self-renewal by regulating Dnmt3aWenhuo Hu, James Dooley, Stephen S Chung, et al.
Research Square|September 11, 2024
Synergistic and antagonistic drug interactions are prevalent but not conserved across acute myeloid leukemia cell linesFatma Neslihan Kalkan, Muhammed Sadik Yildiz, N Ezgi Wood, et al.
Leukemia Research|June 23, 2026
Long-term remission and survival in older adults with IDH-mutated acute myeloid leukemia treated with IDH inhibitorsNilesh Kapoor, Fieke W Hoff, Clayton Jackson, et al.
Scientific Reports|June 3, 2025
Synergistic and antagonistic drug interactions are prevalent but not conserved across acute myeloid leukemia cell linesFatma Neslihan Kalkan, Muhammed Sadik Yildiz, N Ezgi Wood, et al.
Haematologica|January 26, 2013
Mutational analysis of therapy-related myelodysplastic syndromes and acute myelogenous leukemiaAlan H Shih, Stephen S Chung, Emily K Dolezal, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Leukemia Research|April 27, 2024
Racial and ethnic disparities in Acute Myeloid Leukemia: 15-year experience at a safety net hospital systemSharlene Dong, Naveen Premnath, Navid Sadeghi, et al.
Nature Communications|May 5, 2023
Neutrophil metabolomics in severe COVID-19 reveal GAPDH as a suppressor of neutrophil extracellular trap formationYafeng Li, Jessica S Hook, Qing Ding, et al.
Seminars in Oncology|December 5, 2012
A 75-year-old woman with thoracic spinal cord compression and chloroma (granulocytic sarcoma)Madhava Baikaidi, Stephen S Chung, Martin S Tallman, et al.
Nature Communications|November 4, 2021
Convergence of oncogenic cooperation at single-cell and single-gene levels drives leukemic transformationYuxuan Liu, Zhimin Gu, Hui Cao, et al.
Circulation Research|September 5, 2009
Aldose reductase protects against early atherosclerotic lesion formation in apolipoprotein E-null miceSanjay Srivastava, Elena Vladykovskaya, Oleg A Barski, et al.
Blood|January 31, 2015
miR-29a maintains mouse hematopoietic stem cell self-renewal by regulating Dnmt3aWenhuo Hu, James Dooley, Stephen S Chung, et al.
Research Square|September 11, 2024
Synergistic and antagonistic drug interactions are prevalent but not conserved across acute myeloid leukemia cell linesFatma Neslihan Kalkan, Muhammed Sadik Yildiz, N Ezgi Wood, et al.
Leukemia Research|June 23, 2026
Long-term remission and survival in older adults with IDH-mutated acute myeloid leukemia treated with IDH inhibitorsNilesh Kapoor, Fieke W Hoff, Clayton Jackson, et al.
Scientific Reports|June 3, 2025
Synergistic and antagonistic drug interactions are prevalent but not conserved across acute myeloid leukemia cell linesFatma Neslihan Kalkan, Muhammed Sadik Yildiz, N Ezgi Wood, et al.
Haematologica|January 26, 2013
Mutational analysis of therapy-related myelodysplastic syndromes and acute myelogenous leukemiaAlan H Shih, Stephen S Chung, Emily K Dolezal, et al.
Pageof 5